Prostatic acid phosphatase and prostate-specific antigen in prostate cancer. 1982

M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein

Related Publications

M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
February 1983, The Journal of urology,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
December 1986, Urology,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1996, International urology and nephrology,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1988, American journal of clinical oncology,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1990, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1990, The Journal of nuclear medicine and allied sciences,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1985, Scandinavian journal of clinical and laboratory investigation. Supplementum,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1988, The International journal of biological markers,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
August 1988, Hinyokika kiyo. Acta urologica Japonica,
M Kuriyama, and R Loor, and M C Wang, and C Lee, and C S Killian, and L D Papsidero, and H Inaji, and T Nishiura, and N H Slack, and G P Murphy, and T M Chu
January 1991, International urology and nephrology,
Copied contents to your clipboard!